Mindray Medical: Announcement on main operating conditions in the third quarter of 2025
Securities code: 300760 Securities abbreviation: Mindray Medical Announcement number: 2025-033
Shenzhen Mindray Biomedical Electronics Co., Ltd.
Announcement on main operating conditions in the third quarter of 2025
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Main operating conditions in the third quarter of 2025
According to preliminary calculations by Shenzhen Mindray Biomedical Electronics Co., Ltd. (hereinafter referred to as the "Company"), the company's overall operating income in the third quarter of 2025 will achieve positive year-on-year growth, while continuing the trend of quarter-on-quarter improvement in operating income. Among them: the international market has accelerated year-on-year growth in the third quarter, and the international in vitro diagnostic production line is expected to achieve rapid growth; the domestic market will significantly improve and usher in an inflection point as scheduled.
2. Explanation of reasons for changes
Although the domestic market medical equipment bidding has begun to recover since December last year, because the cycle from public bidding to revenue recognition has been significantly lengthened, domestic performance has only reached an inflection point since the third quarter of this year.
3. Other related instructions
The company has not pre-communicated with the accounting firm on the main operating conditions of this time, and the data has not been audited by the accounting firm. The above situation is the result of the company's preliminary calculations. The specific data is subject to the disclosure in the company's third quarter report of 2025. It is only used as a periodic operating situation description for investors' reference and does not constitute a performance commitment. The company's full-year performance cannot be calculated from this. Investors are advised to invest rationally and pay attention to risks.
Announcement is hereby made.
Board of Directors of Shenzhen Mindray Biomedical Electronics Co., Ltd.
August 28, 2025